Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019)
Insulet's (PODD) quarterly Net Equity Issued and Repurchased came in at -$9.1 million in Q2 2019, down 209.9% on a YoY basis from $8.2 million in Q2 2018, and down 200.0% quarter-over-quarter from $9.1 million in Q1 2019.
Analysis
Insulet (PODD) Net Equity Issued and Repurchased (2010 - 2019) Analysis & Trends
Insulet (PODD) has reported Net Equity Issued and Repurchased for 10 consecutive years, with -$9.1 million the latest figure, recorded in Q2 2019.
- For the quarter ending Q2 2019, Net Equity Issued and Repurchased fell 209.9% year-over-year to -$9.1 million; the trailing twelve-month figure through Sep 2020 stood at -$9.1 million (up 32.7% YoY), and the FY2020 full-year result was $477.5 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased slipped to -$9.1 million in Q2 2019 per PODD's latest filing, from $9.1 million in the prior quarter.
- Across five years, Net Equity Issued and Repurchased topped out at $9.1 million in Q1 2019 and bottomed at -$13.5 million in Q4 2018.
- Historically, Net Equity Issued and Repurchased has averaged $1.4 million across 5 years, with a median of $1.6 million in 2015.
- The sharpest annual moves came in 2017 and 2019: Net Equity Issued and Repurchased surged 695.85% in 2017, then sank 209.9% in 2019.
- Over 5 years, Net Equity Issued and Repurchased stood at $808000.0 in 2015, then sank by 99.26% to $6000.0 in 2016, then soared by 47300.0% to $2.8 million in 2017, then tumbled by 573.42% to -$13.5 million in 2018, then jumped by 32.7% to -$9.1 million in 2019.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered -$9.1 million, $9.1 million, and -$13.5 million for Q2 2019, Q1 2019, and Q4 2018 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.76 Bn | 175.16 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.77 Bn | 122.55 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.20 Bn | 108.39 Bn | 6.34 Bn | 20.00 Mn |
| 4 | Stryker | 104.01 Bn | 100.53 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.51 Bn | 62.97 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.80 Bn | 45.55 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.03 Bn | 31.58 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | - |
| 10 | Insulet | 9.35 Bn | 8.82 Bn | 562.60 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2019 | -9.06 Mn |
| Mar 31, 2019 | 9.06 Mn |
| Dec 31, 2018 | -13.46 Mn |
| Sep 30, 2018 | 2.26 Mn |
| Jun 30, 2018 | 8.25 Mn |
| Mar 31, 2018 | 2.96 Mn |
| Sep 30, 2017 | 2.84 Mn |
| Jun 30, 2017 | 1.56 Mn |
| Mar 31, 2017 | 6.34 Mn |
| Dec 31, 2016 | 6,000.00 |
| Sep 30, 2016 | 3.36 Mn |
| Jun 30, 2016 | 694,000.00 |
| Mar 31, 2016 | 796,000.00 |
| Dec 31, 2015 | 808,000.00 |
| Sep 30, 2015 | 554,000.00 |
| Jun 30, 2015 | 1.61 Mn |
| Mar 31, 2015 | 4.88 Mn |
| Dec 31, 2014 | 4.71 Mn |
| Sep 30, 2014 | 1.54 Mn |
| Jun 30, 2014 | 1.78 Mn |